MarketBeat provided consensus price targets and ratings for Liquidia and Ovid Therapeutics.
2 reports, 1 independent
Updated Sep 22
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat provided consensus price targets and ratings for Liquidia and Ovid Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
Related events
- MarketBeat provided consensus price targets and ratings regarding a company involving Lazard on May 27, 2026.
- MarketBeat reported consensus price targets and analyst ratings for TScan Therapeutics and Mereo BioPharma Group.
- MarketBeat has released its consensus rating and target price for Sunshine Biopharma, Inc.
- MarketBeat published consensus price targets and analyst recommendations concerning the Financial Services Industry on September 1, 2026.
- MarketBeat provided consensus price targets and ratings, while DBV Technologies and XTL Biopharmaceuticals compete in the small-cap healthcare market.